Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/31/2012WO2012070034A1 A drug delivery device
05/31/2012WO2012070008A2 Recombinant proteins with a selective inactivation activity on target proteins
05/31/2012WO2012070003A1 Hla-g isoform for use in the treatment of a disease associated with bone resorption
05/31/2012WO2012069836A2 Biologically active complex and its preparation
05/31/2012WO2012069627A1 Covalently linked interleukin-10
05/31/2012WO2012069474A2 A method for reducing potential virus burden in a sample by cyanate treatment
05/31/2012WO2012068936A1 Use of hepatocyte nuclear factor 1α in preparation of drug for treating malignant solid tumor disease
05/31/2012WO2012068627A1 Peptides for the specific binding of rna targets
05/31/2012WO2012042386A3 Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
05/31/2012WO2012040259A3 Modified compstatin with improved stability and binding properties
05/31/2012WO2012037485A9 Methods of inhibiting alphavirus replication and treating alphavirus infection
05/31/2012WO2012036410A3 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
05/31/2012WO2012033789A3 Treatment of diseases
05/31/2012WO2012030535A3 Bacteriophage lytic enzymes as alternative antimicrobials
05/31/2012WO2012027411A9 Compositions and uses of materials with high antimicrobial activity and low toxicity
05/31/2012WO2012024621A3 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
05/31/2012WO2012023811A3 Pharmaceutical composition for suppressing angiogenesis, and method for screening active material for suppressing angiogenesis
05/31/2012WO2012021845A3 Improved hematopoietic stem and progenitor cell therapy
05/31/2012WO2012018877A9 Treating breast cancer with anti-il-19 antibody
05/31/2012WO2012011752A3 Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity
05/31/2012WO2012010128A3 Gelsolin enrichment of blood samples using gold particles
05/31/2012WO2012006634A3 Prostate specific antigen (psa) peptide therapy
05/31/2012WO2011163651A3 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF β-GALACTOCEREBROSIDASE
05/31/2012WO2011161295A3 Use of anticalcineurin compounds for the treatment of pathologies involving ocular neovascularisation
05/31/2012WO2011156453A4 Therapeutic peptides
05/31/2012WO2011156045A3 Tablet formulation of ezatiostat
05/31/2012WO2011140132A9 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
05/31/2012US20120137379 Novel aav's and uses thereof
05/31/2012US20120136141 Integrin Heterodimer And A Subunit Thereof
05/31/2012US20120136043 Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
05/31/2012US20120135983 DNA Damage Repair Inhibitors for the Treatment of Cancer
05/31/2012US20120135942 Beta-hairpin peptidomimetics
05/31/2012US20120135941 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
05/31/2012US20120135940 Pharmaceutical compositions for lipophilic drugs
05/31/2012US20120135939 Cyclosporin Analogs
05/31/2012US20120135938 Polypeptides that Bind TRAIL-R1 and TRAIL-R2
05/31/2012US20120135937 Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
05/31/2012US20120135936 Inhibition of prion protein propagation by receptor associated protein (rap), its derivatives, mimetics and synthetic peptides
05/31/2012US20120135935 Gpr54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
05/31/2012US20120135934 Combined preparation for treating joint diseases
05/31/2012US20120135933 Soluble tumor necrosis factor receptor treatment of medical disorders
05/31/2012US20120135932 Compositions And Methods For Treating Ischemia And Ischemia-Reperfusion Injury
05/31/2012US20120135931 Method of modifying serine protease inhibitors
05/31/2012US20120135930 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
05/31/2012US20120135929 Methods Of Modulating Uric Acid Levels
05/31/2012US20120135928 Method for purifying recombinant fsh
05/31/2012US20120135927 Bone morphogenetic proteins for the treatment of insulin resistance
05/31/2012US20120135926 Peptides for inhibiting igf-1
05/31/2012US20120135925 Covalent Inhibition of Bacterial Quorum Sensing
05/31/2012US20120135924 Prosthesis for Joint Cartilage Repair and Method of Manufacture
05/31/2012US20120135923 Use of Melanocortins to Treat Dyslipidemia
05/31/2012US20120135922 Modified exendins and exendin agonists
05/31/2012US20120135921 Tripetide boronic acid or boronic ester, preparative method and use thereof
05/31/2012US20120135920 Preparation Comprising Insulin, Nicotinamide and an Amino Acid
05/31/2012US20120135919 Polymer-drug conjugates
05/31/2012US20120135918 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
05/31/2012US20120135917 Anti-Gram Negative Bacteria Agent
05/31/2012US20120135916 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
05/31/2012US20120135915 Treatment of traumatic or degenerative neurologic, otologic, or ophthalmologic diseases with targeted protease inhibitors
05/31/2012US20120135914 Etoposide and doxorubicin conjugates for drug delivery
05/31/2012US20120135913 Lysine compounds and their use in site- and chemoselective modification of peptides and proteins
05/31/2012US20120135912 Polypeptide inhibitors of vla4
05/31/2012US20120135521 Antigene locks and therapeutic uses thereof
05/31/2012US20120135496 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof
05/31/2012US20120135495 Neurotoxins with enhanced target specificity
05/31/2012US20120135401 Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory Disease
05/31/2012US20120135376 Collagen Biomaterial Wedge
05/31/2012US20120135092 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
05/31/2012US20120135089 E3 ligase inhibitors
05/31/2012US20120135068 Liposome-encapsulated glutathione for oral administration
05/31/2012US20120135063 Glucuronic acid-containing glucan, process for production of same, and use of same
05/31/2012US20120135037 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
05/31/2012US20120135031 Method of enhancing an immune response
05/31/2012US20120135024 Neisseria meningitidis antigens and compositions
05/31/2012US20120135019 Fviii peptides for immune tolerance induction and immunodiagnostics
05/31/2012US20120135016 Induction of neurogenesis and stem cell therapy in combination with copolymer 1
05/31/2012US20120135000 Methods and compositions for treating ocular disorders
05/31/2012US20120134997 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
05/31/2012US20120134991 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function
05/31/2012US20120134980 Fragmented polymeric compositions and methods for their use
05/31/2012US20120134979 Methods and compositions for the treatment of sickle cell disease
05/31/2012US20120134978 Cross-Linking of Superoxide Dismutase Monomers
05/31/2012US20120134977 Prodrugs containing albumin binding probe
05/31/2012US20120134972 Novel Polypeptides Having Endolysin Activity And Uses Thereof
05/31/2012US20120134969 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
05/31/2012US20120134964 Human matrix metalloproteinase-8 gene delivery enhances the oncolytic activity of a replicating adenovirus
05/31/2012US20120134962 Methods and compositions for tissue regeneration
05/31/2012US20120134961 Interferon-alpha (IFN-alpha) Fused Protein Having IFN-alpha and Cytoplasmic Transduction Peptide (CTP)
05/31/2012US20120134960 Glycosylated human alpha interferon muteins, method for obtaining them and use
05/31/2012US20120134959 Pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
05/31/2012US20120134958 Hydroxyethyl starch-containing polypeptide compositions
05/31/2012US20120134957 Latent phase viral interleukin-10-(vii-10) and uses thereof
05/31/2012US20120134956 Colloidal metal compositions and methods
05/31/2012US20120134955 Pyrimidopyrimidoindazole derivative
05/31/2012US20120134954 Defensin-antigen fusion proteins
05/31/2012US20120134949 Polymeric collagen biomaterials
05/31/2012US20120134925 Application and Uses of PRG4 and Therapeutic Modulation Thereof
05/31/2012US20120134919 Ion substituted calcium phosphate particles
05/31/2012US20120132204 Unit dose dry powder inhaler
05/31/2012CA2818892A1 Adjuvant
1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 3163